URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Wojciech Zareba

Concepts (600)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Electrocardiography
119
1994
773
15.170
Why?
Long QT Syndrome
88
1994
387
14.250
Why?
Defibrillators, Implantable
86
2000
418
13.440
Why?
Myocardial Infarction
82
1994
660
11.420
Why?
Heart Rate
63
1995
461
9.950
Why?
Heart Failure
36
2004
367
8.040
Why?
Death, Sudden, Cardiac
67
1994
294
7.970
Why?
Heart Conduction System
28
1994
153
7.300
Why?
Electrocardiography, Ambulatory
37
1990
93
6.920
Why?
Tachycardia, Ventricular
37
1994
156
6.880
Why?
Ventricular Dysfunction, Left
30
2001
164
6.700
Why?
Arrhythmias, Cardiac
29
1994
246
5.110
Why?
Risk Assessment
64
2001
884
4.670
Why?
Cardiac Resynchronization Therapy
15
2010
89
4.070
Why?
Humans
301
1986
36274
3.840
Why?
Male
227
1986
19675
3.660
Why?
Risk Factors
98
1994
2345
3.620
Why?
Female
218
1986
19838
3.450
Why?
Arrhythmogenic Right Ventricular Dysplasia
11
2003
20
3.390
Why?
Middle Aged
139
1986
9837
3.050
Why?
Mutation
31
1995
1216
3.020
Why?
Ether-A-Go-Go Potassium Channels
13
2002
56
3.010
Why?
Genetic Predisposition to Disease
26
1999
331
2.960
Why?
Diagnosis, Computer-Assisted
8
2005
62
2.930
Why?
Electric Countershock
15
2004
95
2.830
Why?
Ventricular Fibrillation
15
2003
96
2.770
Why?
Coronary Disease
18
1990
258
2.730
Why?
Aged
105
1986
7269
2.690
Why?
Coronary Artery Disease
11
2003
96
2.670
Why?
Survival Analysis
41
1997
606
2.560
Why?
Myocardial Ischemia
15
1994
118
2.470
Why?
Stroke Volume
26
2002
154
2.470
Why?
Proportional Hazards Models
56
1998
450
2.470
Why?
KCNQ1 Potassium Channel
15
2002
76
2.440
Why?
Treatment Outcome
52
2001
2615
2.350
Why?
Adrenergic beta-Antagonists
27
1998
174
2.270
Why?
Prognosis
45
1994
1083
2.250
Why?
Adult
108
1986
11351
2.170
Why?
Atrial Fibrillation
10
2003
110
2.090
Why?
Cardiac Pacing, Artificial
8
2005
158
2.090
Why?
Anti-Arrhythmia Agents
10
1994
77
2.080
Why?
Follow-Up Studies
54
1994
1855
2.010
Why?
Genotype
37
1995
490
2.010
Why?
Cardiology
5
1991
54
1.980
Why?
Heart Arrest
23
1994
153
1.800
Why?
Heart Diseases
8
1991
142
1.790
Why?
Sodium Channels
10
1998
120
1.790
Why?
Sotalol
6
2003
16
1.720
Why?
Tachycardia, Sinus
3
1997
8
1.710
Why?
Polymorphism, Genetic
9
2001
201
1.700
Why?
Pacemaker, Artificial
7
2004
162
1.560
Why?
Time Factors
36
1990
3182
1.550
Why?
Torsades de Pointes
8
1997
32
1.540
Why?
Syncope
22
1994
115
1.530
Why?
Romano-Ward Syndrome
7
2007
37
1.530
Why?
Coronary Artery Bypass
4
2003
106
1.500
Why?
Signal Processing, Computer-Assisted
13
1995
101
1.480
Why?
Algorithms
10
2003
541
1.470
Why?
Recurrence
28
1997
691
1.440
Why?
Ventricular Premature Complexes
7
2003
18
1.430
Why?
Multivariate Analysis
23
1995
541
1.410
Why?
Randomized Controlled Trials as Topic
7
2003
411
1.400
Why?
Periodicals as Topic
2
2011
79
1.400
Why?
Ventricular Function, Left
7
2005
95
1.340
Why?
Potassium Channels, Voltage-Gated
6
2002
36
1.320
Why?
Phenotype
27
1995
763
1.310
Why?
Echocardiography
14
2000
228
1.310
Why?
Cardiomyopathy, Dilated
7
1994
42
1.300
Why?
Survival Rate
25
2000
618
1.260
Why?
Predictive Value of Tests
19
1994
606
1.250
Why?
Cardiovascular Diseases
10
2001
277
1.200
Why?
Severity of Illness Index
21
2001
922
1.170
Why?
Potassium Channels
8
2002
130
1.140
Why?
Sex Factors
16
1995
597
1.140
Why?
Adolescent
45
1986
4766
1.130
Why?
Kaplan-Meier Estimate
21
2007
222
1.120
Why?
Sensitivity and Specificity
20
1998
905
1.110
Why?
Prospective Studies
31
1999
1689
1.110
Why?
Ventricular Function
4
1995
36
1.090
Why?
Multicenter Studies as Topic
8
2001
129
1.080
Why?
Magnetic Resonance Imaging
4
2006
991
1.060
Why?
Retrospective Studies
23
1998
2267
1.050
Why?
Heart Ventricles
12
1990
207
1.050
Why?
Cardiac Resynchronization Therapy Devices
3
2011
13
1.030
Why?
Journal Impact Factor
2
2011
5
1.010
Why?
Bundle-Branch Block
6
2003
51
1.010
Why?
Aza Compounds
3
2008
23
0.990
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2002
48
0.990
Why?
Quinolines
3
2008
44
0.970
Why?
Environmental Exposure
4
2004
202
0.960
Why?
Anti-Infective Agents
3
2008
75
0.940
Why?
Biological Markers
16
2000
560
0.940
Why?
Air Pollutants
6
2001
179
0.930
Why?
Heterozygote
10
1998
125
0.930
Why?
Mutation, Missense
5
2002
87
0.930
Why?
Cause of Death
10
2001
162
0.900
Why?
Registries
21
1998
223
0.890
Why?
Telemedicine
3
2005
43
0.880
Why?
Practice Guidelines as Topic
7
2007
302
0.880
Why?
Angina, Unstable
6
1994
34
0.860
Why?
Societies, Medical
5
2001
138
0.840
Why?
Child
32
1994
4155
0.840
Why?
European Continental Ancestry Group
5
2006
234
0.820
Why?
Glomerular Filtration Rate
2
2006
88
0.810
Why?
Carbon
4
2004
81
0.810
Why?
Diabetes Mellitus, Type 2
4
2001
224
0.800
Why?
Muscle Proteins
2
2008
142
0.800
Why?
Cholesterol Ester Transfer Proteins
2
2007
15
0.790
Why?
Research Design
5
2002
336
0.780
Why?
Heart Failure, Diastolic
1
2011
1
0.770
Why?
Cohort Studies
14
1994
969
0.760
Why?
Lipoproteins
4
2001
98
0.750
Why?
United States
22
1991
2688
0.740
Why?
C-Reactive Protein
10
2002
122
0.730
Why?
Young Adult
17
2008
1059
0.730
Why?
Exercise
5
2001
182
0.730
Why?
Reproducibility of Results
15
1998
877
0.720
Why?
Sequence Deletion
2
2007
129
0.720
Why?
Chi-Square Distribution
16
1999
344
0.710
Why?
Posture
1
2010
110
0.700
Why?
von Willebrand Factor
4
1999
59
0.700
Why?
African Continental Ancestry Group
3
2006
125
0.690
Why?
Child, Preschool
22
1995
2660
0.690
Why?
Air Pollution
4
2005
44
0.680
Why?
Terminology as Topic
2
2006
109
0.670
Why?
DNA
2
2011
845
0.670
Why?
Hospitalization
7
2004
399
0.670
Why?
Lipids
10
1999
168
0.660
Why?
Consensus Development Conferences as Topic
1
2008
7
0.660
Why?
Ventricular Dysfunction
1
2008
7
0.660
Why?
Cation Transport Proteins
3
2002
22
0.660
Why?
Incidence
13
2006
685
0.650
Why?
Kidney Diseases
2
2009
170
0.640
Why?
Angioplasty, Balloon, Coronary
2
2005
66
0.640
Why?
Hypertension
3
2003
301
0.630
Why?
Obesity
3
2000
339
0.620
Why?
Smoking
3
2000
399
0.620
Why?
Infant
17
1995
2278
0.600
Why?
Physicians
2
2005
157
0.590
Why?
Hyperglycemia
1
2008
89
0.590
Why?
Age Factors
12
1995
1128
0.580
Why?
Cardiomyopathies
5
2003
82
0.580
Why?
Angiotensinogen
1
2006
8
0.570
Why?
Risk
9
2004
368
0.560
Why?
Polymorphism, Single Nucleotide
5
2007
90
0.560
Why?
Regression Analysis
11
1994
527
0.560
Why?
Particulate Matter
5
2006
48
0.560
Why?
Probability
10
2001
302
0.560
Why?
Models, Biological
2
2011
1008
0.550
Why?
Comorbidity
9
1999
380
0.550
Why?
Mental Health
1
2007
83
0.540
Why?
Attitude of Health Personnel
2
2005
289
0.540
Why?
Angioplasty, Balloon
1
2006
67
0.530
Why?
Heart
7
1995
236
0.530
Why?
Diabetes Mellitus
2
2001
169
0.530
Why?
Sex Distribution
9
2003
160
0.520
Why?
Models, Economic
1
2005
28
0.520
Why?
Circadian Rhythm
2
2004
84
0.520
Why?
Cholesterol, HDL
5
2003
62
0.520
Why?
Trans-Activators
3
2002
365
0.520
Why?
Aged, 80 and over
14
2004
2529
0.510
Why?
Gonadal Steroid Hormones
1
2005
35
0.510
Why?
Public Opinion
1
2005
17
0.500
Why?
Critical Illness
1
2005
52
0.490
Why?
Health Care Costs
1
2005
113
0.480
Why?
Choice Behavior
1
2005
46
0.480
Why?
Tachycardia, Supraventricular
3
1990
19
0.480
Why?
Sequence Analysis, Protein
1
2003
14
0.470
Why?
Ion Channels
9
1995
153
0.460
Why?
Steroids
1
2004
54
0.460
Why?
Statistics, Nonparametric
11
2001
262
0.450
Why?
Reference Values
6
1999
439
0.450
Why?
Case-Control Studies
9
1997
617
0.450
Why?
DNA-Binding Proteins
3
2002
685
0.450
Why?
Pirenzepine
1
2003
4
0.440
Why?
Jervell-Lange Nielsen Syndrome
3
2002
11
0.440
Why?
Sequence Alignment
1
2003
191
0.440
Why?
Haloperidol
1
2003
38
0.440
Why?
Myocardial Contraction
3
2011
111
0.430
Why?
Myocardium
3
2006
294
0.430
Why?
Autonomic Nervous System
5
2001
68
0.420
Why?
Ventricular Remodeling
3
2010
38
0.420
Why?
Particle Size
9
2002
199
0.420
Why?
Drug Approval
1
2002
20
0.400
Why?
Logistic Models
11
2000
611
0.400
Why?
Age Distribution
8
2003
221
0.390
Why?
Electrophysiology
9
1994
247
0.390
Why?
Antipsychotic Agents
1
2003
114
0.390
Why?
Inflammation
6
2002
534
0.380
Why?
Patient Selection
4
2008
212
0.380
Why?
Disease Progression
7
2002
521
0.380
Why?
Blood Urea Nitrogen
4
2005
43
0.360
Why?
Monitoring, Physiologic
2
2010
100
0.350
Why?
Spain
4
2008
19
0.350
Why?
Analysis of Variance
6
1994
736
0.350
Why?
Mortality
3
1997
89
0.350
Why?
Metabolic Syndrome X
3
2003
60
0.350
Why?
Odds Ratio
8
1995
315
0.350
Why?
Cholesterol
3
1997
137
0.340
Why?
Ion Channel Gating
2
2011
127
0.340
Why?
Myocardial Revascularization
2
2006
22
0.330
Why?
Biopsy
2
2010
362
0.330
Why?
Recovery of Function
2
2009
107
0.330
Why?
Equipment Design
5
2006
248
0.320
Why?
Hospital Mortality
3
2006
137
0.320
Why?
Baroreflex
3
2004
22
0.320
Why?
Blood Pressure
4
2007
467
0.310
Why?
Connexin 43
2
2006
40
0.310
Why?
Up-Regulation
3
2006
363
0.310
Why?
Diphenhydramine
1
1997
9
0.310
Why?
Histamine H1 Antagonists
1
1997
16
0.310
Why?
DNA Mutational Analysis
5
2002
189
0.310
Why?
Clinical Trials as Topic
6
2002
671
0.300
Why?
Evidence-Based Medicine
2
2009
202
0.300
Why?
ROC Curve
5
1998
126
0.300
Why?
Death
2
2003
23
0.290
Why?
KCNQ Potassium Channels
4
2002
18
0.290
Why?
Equipment Failure
4
2008
72
0.290
Why?
Asthma
3
1999
317
0.280
Why?
Fibrin Fibrinogen Degradation Products
4
1999
50
0.280
Why?
Women's Health
1
1997
60
0.280
Why?
New York
6
2001
1305
0.280
Why?
Phospholipases A
2
2006
37
0.280
Why?
Body Mass Index
3
2000
218
0.280
Why?
Angina Pectoris
4
1994
49
0.270
Why?
Plasminogen Activator Inhibitor 1
3
1999
40
0.270
Why?
Inhalation Exposure
2
2007
88
0.270
Why?
Hemodynamics
2
2002
272
0.270
Why?
Pregnancy Complications, Cardiovascular
3
1998
38
0.260
Why?
Genetic Testing
5
2003
96
0.260
Why?
Databases, Factual
2
2005
156
0.250
Why?
Prevalence
3
2003
562
0.250
Why?
Infant, Newborn
8
2007
1844
0.250
Why?
Therapy, Computer-Assisted
2
2008
12
0.240
Why?
Coronary Vessels
2
2004
132
0.240
Why?
Canada
3
2007
75
0.240
Why?
Blood Glucose
3
2001
464
0.240
Why?
Flecainide
2
2001
12
0.230
Why?
Testosterone
2
2004
158
0.230
Why?
Confidence Intervals
3
2007
165
0.230
Why?
Convalescence
3
1994
19
0.230
Why?
Pedigree
3
2002
231
0.230
Why?
Dose-Response Relationship, Drug
3
1997
1117
0.230
Why?
Enzyme-Linked Immunosorbent Assay
3
1999
462
0.230
Why?
Patient Admission
2
2007
85
0.220
Why?
Ventricular Dysfunction, Right
2
2009
18
0.220
Why?
Thrombosis
4
1999
200
0.220
Why?
International Cooperation
2
1998
69
0.220
Why?
Age of Onset
3
2001
126
0.210
Why?
Japan
2
2007
30
0.210
Why?
Combined Modality Therapy
4
1986
486
0.210
Why?
Remote Sensing Technology
1
2012
2
0.210
Why?
Serum Amyloid A Protein
4
2002
23
0.210
Why?
Cross-Over Studies
2
2009
128
0.200
Why?
Ventricular Function, Right
3
2005
26
0.200
Why?
Thrombospondins
1
2011
13
0.200
Why?
Emotions
2
2001
91
0.200
Why?
Defibrillators
1
2011
6
0.200
Why?
Arteritis
1
2011
15
0.200
Why?
Israel
2
2007
38
0.200
Why?
Ventricular Outflow Obstruction
1
2011
11
0.200
Why?
Oxidants, Photochemical
1
2011
28
0.200
Why?
Survivors
2
2006
118
0.200
Why?
Coronary Care Units
1
2011
18
0.200
Why?
Genetic Variation
2
2008
151
0.200
Why?
Hemostasis
2
1999
62
0.200
Why?
Referral and Consultation
2
2010
196
0.200
Why?
Cardiotoxins
1
2011
3
0.190
Why?
Drug Therapy, Combination
2
2008
382
0.190
Why?
Guideline Adherence
2
2008
83
0.190
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.190
Why?
Menopause
1
2011
43
0.190
Why?
Tachycardia, Paroxysmal
1
2010
11
0.190
Why?
Enalapril
1
2010
6
0.190
Why?
Spironolactone
1
2010
12
0.190
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Heart Defects, Congenital
1
2011
103
0.190
Why?
Ozone
1
2011
83
0.190
Why?
Language
1
2011
28
0.190
Why?
Databases, Genetic
1
2010
26
0.190
Why?
Heart Function Tests
3
2001
33
0.190
Why?
Pattern Recognition, Automated
2
2005
26
0.190
Why?
Diagnosis, Differential
3
2000
874
0.190
Why?
Drug Evaluation, Preclinical
1
2011
76
0.190
Why?
Gene Frequency
2
2006
88
0.190
Why?
Electrodes, Implanted
1
2011
57
0.190
Why?
Cardiology Service, Hospital
1
2010
3
0.180
Why?
Societies, Nursing
1
2010
3
0.180
Why?
Primary Prevention
2
2007
58
0.180
Why?
Heavy Ions
1
2010
2
0.180
Why?
Guidelines as Topic
1
2011
89
0.180
Why?
Adrenergic beta-Agonists
2
1999
51
0.180
Why?
Reference Standards
1
2010
45
0.180
Why?
Hypertriglyceridemia
2
2006
24
0.180
Why?
Forecasting
3
1998
177
0.180
Why?
Hospital Units
1
2010
20
0.180
Why?
Blood Coagulation Factors
4
2000
50
0.180
Why?
Disease-Free Survival
3
2001
198
0.180
Why?
Life Change Events
1
2010
106
0.180
Why?
Magnetic Resonance Angiography
1
2010
37
0.180
Why?
Internet
2
2007
98
0.180
Why?
Acute Coronary Syndrome
1
2009
10
0.180
Why?
Physician's Practice Patterns
2
2008
243
0.170
Why?
Radiation Dosage
1
2010
125
0.170
Why?
Critical Care
1
2010
64
0.170
Why?
Germany
4
2005
26
0.170
Why?
Happiness
1
2009
12
0.170
Why?
Silicones
1
2009
27
0.170
Why?
Statistics as Topic
3
2001
185
0.170
Why?
Tachycardia
2
1986
67
0.160
Why?
Hemostasis, Surgical
1
2008
12
0.160
Why?
Lipase
1
2008
16
0.160
Why?
Lipoprotein(a)
1
2008
15
0.160
Why?
Apolipoprotein A-I
1
2008
23
0.160
Why?
Punctures
1
2008
24
0.160
Why?
Coronary Angiography
3
1998
85
0.160
Why?
Coagulants
1
2008
13
0.160
Why?
Conserved Sequence
1
2009
103
0.160
Why?
Double-Blind Method
2
2005
992
0.160
Why?
Acetanilides
1
2008
9
0.160
Why?
Vagus Nerve
1
2008
40
0.160
Why?
Hypercholesterolemia
2
2005
50
0.160
Why?
Asian Continental Ancestry Group
1
2008
30
0.160
Why?
Chromatography, High Pressure Liquid
3
2002
208
0.160
Why?
Diagnostic Errors
1
2009
90
0.160
Why?
Femoral Artery
1
2008
80
0.160
Why?
Siblings
1
2008
36
0.160
Why?
Delayed Rectifier Potassium Channels
1
2008
10
0.160
Why?
Atrial Flutter
1
2008
25
0.160
Why?
Triglycerides
2
2003
104
0.160
Why?
Coronary Stenosis
2
2004
7
0.160
Why?
Fractals
3
2001
7
0.150
Why?
Cost-Benefit Analysis
2
2005
215
0.150
Why?
Catheter Ablation
1
2009
73
0.150
Why?
Discriminant Analysis
1
2007
22
0.150
Why?
Medical History Taking
1
2008
62
0.150
Why?
Piperazines
1
2008
74
0.150
Why?
Postoperative Complications
2
2001
733
0.150
Why?
Quality of Life
2
2007
502
0.150
Why?
African Americans
1
2010
219
0.150
Why?
Aryldialkylphosphatase
1
2007
6
0.150
Why?
Sodium
1
2008
298
0.150
Why?
Europe
3
2011
80
0.150
Why?
Natriuretic Peptide, Brain
1
2007
11
0.150
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2007
5
0.150
Why?
Pregnancy, High-Risk
1
2007
14
0.150
Why?
Cardiac Output, Low
1
2007
16
0.150
Why?
International Normalized Ratio
1
2006
8
0.150
Why?
E-Selectin
1
2006
17
0.150
Why?
Patient Education as Topic
2
2005
214
0.150
Why?
Vehicle Emissions
1
2007
23
0.140
Why?
Hypolipidemic Agents
2
2002
26
0.140
Why?
Hemorrhage
1
2008
180
0.140
Why?
Kidney
1
2010
586
0.140
Why?
NADPH Oxidase
1
2007
30
0.140
Why?
Radiotherapy, High-Energy
1
2006
24
0.140
Why?
Aging
2
1998
707
0.140
Why?
Diabetic Angiopathies
1
2007
34
0.140
Why?
Point Mutation
2
2003
172
0.140
Why?
User-Computer Interface
1
2007
42
0.140
Why?
Threonine
1
2006
29
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
66
0.140
Why?
Methionine
1
2006
52
0.140
Why?
Education, Medical, Continuing
1
2007
64
0.140
Why?
Protein Precursors
1
2007
84
0.140
Why?
Homozygote
1
2006
97
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
267
0.140
Why?
Rest
1
2006
22
0.140
Why?
Surgical Procedures, Elective
1
2006
32
0.140
Why?
Health Personnel
1
2006
59
0.140
Why?
Outcome Assessment (Health Care)
2
2005
301
0.130
Why?
Electrophysiologic Techniques, Cardiac
1
2005
24
0.130
Why?
Arousal
2
2000
56
0.130
Why?
Paper
1
2005
8
0.130
Why?
Pregnancy Outcome
1
2007
137
0.130
Why?
Apolipoproteins B
2
2000
153
0.130
Why?
Information Storage and Retrieval
1
2005
29
0.130
Why?
Poland
1
2005
12
0.130
Why?
Stress, Psychological
1
2009
285
0.130
Why?
Dehydroepiandrosterone Sulfate
1
2005
7
0.130
Why?
Epidemiologic Studies
1
2005
22
0.130
Why?
Intercellular Adhesion Molecule-1
1
2006
125
0.130
Why?
Medical Records Systems, Computerized
1
2005
34
0.130
Why?
Zinc Oxide
1
2005
7
0.130
Why?
Follicle Stimulating Hormone
1
2005
52
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
48
0.130
Why?
Diabetes Complications
1
2005
66
0.130
Why?
Heart Rupture, Post-Infarction
1
2004
1
0.130
Why?
Insulin
3
1999
668
0.130
Why?
Molecular Sequence Data
3
2002
1988
0.130
Why?
Peptide Fragments
1
2007
282
0.130
Why?
Contrast Media
1
2007
267
0.130
Why?
Prostheses and Implants
1
2005
87
0.130
Why?
Amino Acid Sequence
2
2003
1195
0.120
Why?
Software
1
2005
125
0.120
Why?
Postoperative Period
1
2004
84
0.120
Why?
Sympathectomy
1
2004
21
0.120
Why?
Intermittent Claudication
1
2004
10
0.120
Why?
Heterozygote Detection
2
1999
25
0.120
Why?
Genes, Recessive
1
2003
38
0.110
Why?
Primary Health Care
1
2008
487
0.110
Why?
Endpoint Determination
1
2003
31
0.110
Why?
Thioridazine
1
2003
1
0.110
Why?
Risk Sharing, Financial
1
2003
4
0.110
Why?
Estradiol
1
2004
194
0.110
Why?
Hyperlipidemias
1
2003
45
0.110
Why?
Drug Labeling
1
2003
12
0.110
Why?
Benzodiazepines
1
2003
26
0.110
Why?
Dopamine Antagonists
1
2003
22
0.110
Why?
Apolipoproteins
4
2000
41
0.110
Why?
Atropine
1
2002
33
0.110
Why?
Lipoproteins, HDL
2
1997
33
0.110
Why?
Androgens
1
2004
141
0.110
Why?
History, 20th Century
2
1991
244
0.110
Why?
Exercise Test
3
1994
101
0.100
Why?
United States Food and Drug Administration
1
2002
45
0.100
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2001
3
0.100
Why?
Hyperhomocysteinemia
1
2001
3
0.100
Why?
Leukocyte Count
1
2001
161
0.100
Why?
Blood Proteins
1
2001
95
0.100
Why?
Endothelium, Vascular
2
2001
406
0.100
Why?
Gene Expression Profiling
1
2003
301
0.100
Why?
Sex Characteristics
2
1998
138
0.100
Why?
World Health
2
2011
63
0.090
Why?
Cardiolipins
1
2000
7
0.090
Why?
Models, Molecular
3
2002
355
0.090
Why?
Diabetes Mellitus, Type 1
1
2001
166
0.090
Why?
Longitudinal Studies
2
1997
395
0.090
Why?
Autoantibodies
1
2000
98
0.090
Why?
Electroencephalography
1
2000
176
0.090
Why?
Latex Fixation Tests
1
1999
18
0.090
Why?
Swimming
1
1999
9
0.090
Why?
Questionnaires
1
2005
1004
0.090
Why?
Amino Acid Substitution
2
2007
124
0.080
Why?
Polymorphism, Single-Stranded Conformational
3
2002
40
0.080
Why?
Acoustic Stimulation
1
1999
173
0.080
Why?
Creatinine
2
2007
127
0.080
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2006
15
0.080
Why?
Codon, Nonsense
2
2007
56
0.080
Why?
Physicians, Family
2
2008
109
0.080
Why?
Models, Animal
2
2006
138
0.080
Why?
Lipoproteins, LDL
1
1997
31
0.070
Why?
Systole
2
2005
39
0.070
Why?
Membrane Potentials
2
2007
340
0.070
Why?
Phospholipases A2
2
2006
28
0.070
Why?
Sleep
2
2001
59
0.070
Why?
Family Health
3
1998
90
0.070
Why?
Rabbits
2
2006
697
0.070
Why?
Amiodarone
2
2002
10
0.070
Why?
Action Potentials
2
1990
250
0.070
Why?
Cerebrovascular Disorders
1
1997
115
0.070
Why?
Chromosomes, Human, Pair 7
1
1995
21
0.070
Why?
Chromosomes, Human, Pair 3
1
1995
19
0.070
Why?
Chromosomes, Human, Pair 11
1
1995
30
0.070
Why?
Life Tables
2
2004
39
0.070
Why?
Family
2
2001
201
0.070
Why?
Administration, Inhalation
2
2005
175
0.070
Why?
Genetic Markers
2
2003
134
0.070
Why?
Pregnancy
3
1998
1966
0.070
Why?
Suicide, Attempted
1
1997
210
0.060
Why?
Sputum
2
2004
57
0.060
Why?
Nitric Oxide
2
2004
250
0.060
Why?
Metoprolol
2
2000
10
0.060
Why?
Atenolol
2
2000
13
0.060
Why?
Blood Coagulation
2
2000
67
0.050
Why?
Sequence Analysis, DNA
2
2002
166
0.050
Why?
Nonlinear Dynamics
2
2001
35
0.050
Why?
Precipitating Factors
1
2011
6
0.050
Why?
Genome-Wide Association Study
1
2011
21
0.050
Why?
Genetic Association Studies
1
2011
19
0.050
Why?
Glucose Intolerance
1
2011
25
0.050
Why?
Glucose Tolerance Test
1
2011
68
0.050
Why?
Animals
4
2006
16093
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
Environmental Monitoring
1
2011
62
0.050
Why?
Echocardiography, Doppler
1
2011
53
0.050
Why?
Computers, Handheld
1
2010
10
0.050
Why?
RNA, Messenger
2
2006
1863
0.050
Why?
Minnesota
1
2010
27
0.050
Why?
Atmosphere
1
2010
1
0.050
Why?
National Institutes of Health (U.S.)
2
2001
63
0.050
Why?
Climate
1
2010
4
0.050
Why?
Polymerase Chain Reaction
2
2003
596
0.050
Why?
Blood Volume
1
2010
53
0.050
Why?
Endocardium
1
2010
9
0.050
Why?
Desmosomes
1
2010
4
0.050
Why?
Oocytes
1
2011
135
0.040
Why?
Temperature
1
2010
242
0.040
Why?
Xenopus laevis
1
2011
167
0.040
Why?
Protein Structure, Secondary
1
2009
86
0.040
Why?
Models, Statistical
1
2011
226
0.040
Why?
Obesity, Morbid
1
2010
50
0.040
Why?
Dose-Response Relationship, Radiation
1
2010
219
0.040
Why?
Causality
1
2009
45
0.040
Why?
Early Ambulation
1
2008
5
0.040
Why?
Angiography
1
2009
93
0.040
Why?
Computer Simulation
1
2011
302
0.040
Why?
Fibrinogen
2
1999
149
0.040
Why?
Health Care Surveys
1
2010
161
0.040
Why?
Continental Population Groups
1
2010
121
0.040
Why?
Administration, Topical
1
2008
89
0.040
Why?
Decision Support Systems, Clinical
1
2008
22
0.040
Why?
Pressure
1
2008
130
0.040
Why?
Computational Biology
1
2009
67
0.040
Why?
Interviews as Topic
1
2009
177
0.040
Why?
Minority Groups
1
2008
56
0.040
Why?
Oscillometry
1
2008
25
0.040
Why?
Chromosome Mapping
2
1995
227
0.040
Why?
Genetic Linkage
2
1995
158
0.040
Why?
Frameshift Mutation
1
2007
22
0.040
Why?
RNA Splice Sites
1
2007
17
0.040
Why?
Patient Satisfaction
1
2009
226
0.040
Why?
Netherlands
1
2007
29
0.040
Why?
Mutagenesis, Insertional
1
2007
53
0.040
Why?
Ion Transport
1
2007
70
0.040
Why?
Postpartum Period
1
2007
38
0.040
Why?
Rats, Inbred SHR
1
2007
43
0.040
Why?
Sulfur Dioxide
1
2006
11
0.040
Why?
Injections, Intraperitoneal
1
2007
84
0.040
Why?
Glutamine
1
2007
63
0.040
Why?
Aspartic Acid
1
2007
46
0.040
Why?
Parity
1
2007
49
0.040
Why?
Telemetry
1
2007
26
0.040
Why?
Patient Readmission
1
2007
39
0.040
Why?
Aerosols
1
2007
115
0.040
Why?
Carbon Monoxide
1
2006
53
0.040
Why?
Internationality
1
2006
26
0.040
Why?
Nitrous Oxide
1
2006
40
0.040
Why?
Arginine
1
2007
108
0.040
Why?
Automobile Driving
1
2007
33
0.040
Why?
Glutamic Acid
1
2007
97
0.030
Why?
Protein Transport
1
2007
168
0.030
Why?
Enzyme Inhibitors
1
2008
422
0.030
Why?
Models, Cardiovascular
1
2006
70
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Gap Junctions
1
2006
66
0.030
Why?
Potassium
1
2007
304
0.030
Why?
Database Management Systems
1
2005
13
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Gestational Age
1
2007
339
0.030
Why?
Placebo Effect
1
2005
35
0.030
Why?
Carbazoles
1
2005
28
0.030
Why?
Artificial Intelligence
1
2005
23
0.030
Why?
Lipopolysaccharides
1
2007
211
0.030
Why?
Protein Structure, Tertiary
1
2007
347
0.030
Why?
Length of Stay
1
2007
287
0.030
Why?
Equipment Failure Analysis
1
2005
71
0.030
Why?
Massachusetts
1
2005
32
0.030
Why?
Advisory Committees
1
2005
21
0.030
Why?
Smoking Cessation
1
2006
80
0.030
Why?
Radiotherapy
1
2006
198
0.030
Why?
Lymphocyte Subsets
1
2004
27
0.030
Why?
Respiratory System
1
2005
46
0.030
Why?
Heart Atria
1
2005
68
0.030
Why?
Cardiovascular System
1
2004
46
0.030
Why?
Ganglionectomy
1
2004
7
0.030
Why?
Blotting, Western
1
2006
645
0.030
Why?
Respiration
1
2004
181
0.030
Why?
Blood Chemical Analysis
1
2003
39
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
542
0.030
Why?
Factor Analysis, Statistical
1
2003
57
0.030
Why?
Diseases in Twins
1
2003
38
0.030
Why?
Rare Diseases
1
2003
27
0.030
Why?
Clinical Protocols
1
2003
106
0.030
Why?
Oxidative Stress
1
2007
346
0.030
Why?
Nucleic Acid Denaturation
1
2003
48
0.030
Why?
Immunohistochemistry
1
2006
1064
0.030
Why?
Entropy
1
2002
9
0.030
Why?
Exons
1
2003
168
0.030
Why?
Introns
1
2003
111
0.030
Why?
Hearing Loss, Sensorineural
1
2002
20
0.030
Why?
Principal Component Analysis
1
2001
31
0.030
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2001
5
0.020
Why?
Mexiletine
1
2001
11
0.020
Why?
Drug Monitoring
1
2001
41
0.020
Why?
beta 2-Glycoprotein I
1
2000
4
0.020
Why?
Cytokines
1
2004
565
0.020
Why?
Mitral Valve Insufficiency
1
2000
24
0.020
Why?
Immunoglobulin M
1
2000
141
0.020
Why?
Nadolol
1
2000
5
0.020
Why?
Administration, Oral
1
2001
308
0.020
Why?
Propranolol
1
2000
82
0.020
Why?
Bias (Epidemiology)
1
2000
44
0.020
Why?
Automation
1
1999
31
0.020
Why?
Binding Sites
1
2002
690
0.020
Why?
Factor VII
1
1999
8
0.020
Why?
Factor VIIa
1
1999
16
0.020
Why?
Pilot Projects
1
2001
442
0.020
Why?
Evaluation Studies as Topic
1
1999
245
0.020
Why?
Chronic Disease
1
2001
522
0.020
Why?
Glycoproteins
1
2000
201
0.020
Why?
Rats
1
2007
4289
0.020
Why?
Stress, Physiological
1
2000
107
0.020
Why?
Immunoglobulin G
1
2000
488
0.020
Why?
Acute Disease
1
2000
586
0.020
Why?
Abortion, Induced
1
1998
46
0.020
Why?
Base Sequence
1
2002
1683
0.020
Why?
Thallium Radioisotopes
1
1997
14
0.020
Why?
Gene Expression
1
2000
751
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?

Visualizations


Zareba's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department